Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 28 checked references that resolve
resolves10.1016/S1474-4422(11)70250-2MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study
resolves10.1073/pnas.0404848101Functional immunomics: Microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induced diabetes
resolves10.1038/nm0302-295Autoantigen microarrays for multiplex characterization of autoantibody responses
resolves10.1001/archneur.64.10.nct70002Induction of Antigen-Specific Tolerance in Multiple Sclerosis After Immunization With DNA Encoding Myelin Basic Protein in a Randomized, Placebo-Controlled Phase 1/2 Trial
resolves10.1002/ana.21370Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis
resolves10.1038/nm1344Lipid microarrays identify key mediators of autoimmune brain inflammation
resolves10.1073/pnas.0806310105Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis
resolves10.1038/nature06880Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor
resolves10.1038/nbt859Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis
resolves10.1016/S1474-4422(11)70045-XClinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study
resolves10.1002/ana.20703Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
resolves10.1016/S1474-4422(09)70275-3Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score
resolves10.1038/358155a0Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
resolves10.1038/nri724Epitope spreading in immune-mediated diseases: implications for immunotherapy
resolves10.1093/brain/123.3.508Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: Epitope spreading versus clonal persistence
resolves10.1038/ni1430CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE
resolves10.1038/nm1202Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis
resolves10.1172/JCI29251Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis
resolves10.1084/jem.20031579Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
resolves10.1002/jnr.20852Secondary progressive in contrast to relapsing‐remitting multiple sclerosis patients show a normal CD4<sup>+</sup>CD25<sup>+</sup> regulatory T‐cell function and FOXP3 expression
resolves10.1002/ana.22693Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis
resolves10.1073/pnas.1009201107An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis
resolves10.1073/pnas.1120611109Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.